Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma

BACKGROUND: Osteosarcoma is the most common of all the bone malignancies and accounts for 30-80 % of the primary skeletal sarcomas. The overall survival rate of patients with osteosarcoma is < 20 % suggesting poor prognosis. METHODS: The present study demonstrates the effect of retinoic acid chlo...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yan-Guo, Zhu, Lan-Yu, Wang, Chen-Yu, Zhang, Bo-Yan, Wang, Qing-Yu, Li, Rui-Yan, Liu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501080/
https://www.ncbi.nlm.nih.gov/pubmed/26170203
http://dx.doi.org/10.1186/s12944-015-0068-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501080/
https://www.ncbi.nlm.nih.gov/pubmed/26170203
http://dx.doi.org/10.1186/s12944-015-0068-4

Ejemplares similares